◄ back to all posts
Financial data and stock pages provided by
Fintel.io
#WhatYouMissed On RIA This Week: 05-29-20
May 29, 2020
Robertson: Investing For The End Game
May 28, 2020
◄ back to all posts
JNJ: Johnson & Johnson Stock
Written by | Jul 6, 2018
Print FriendlySIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 390,577.97 |
| Enterprise Value ($M) | 403,723.69 |
| Book Value ($M) | 58,955.00 |
| Book Value / Share | 22.20 |
| Price / Book | 6.63 |
| NCAV ($M) | -49,085.00 |
| NCAV / Share | -18.49 |
| Price / NCAV | -7.96 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.17 |
| Return on Assets (ROA) | 0.10 |
| Return on Equity (ROE) | 0.25 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.13 |
| Current Ratio | 1.44 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 41,987.00 |
| Assets | 150,027.00 |
| Liabilities | 91,072.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | n/a |
| Net Income | 15,297.00 |
| Earnings Per Share Diluted | 5.61 |
| Earnings Per Share Basic | 5.70 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 22,201.00 |
| Cash from Investing | -3,167.00 |
| Cash from Financing | -3,167.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | State Street Corp | 5.77 | 0.10 | |
| 13G/A | Vanguard Group Inc | 8.67 | 3.15 | |
| 13G/A | BlackRock Inc. | 7.30 | 5.06 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| Quarterly Report – 10-Q | ||
| JNJ / Johnson & Johnson 10-K – Annual Report – 10-K 2019 | ||
| JNJ / Johnson & Johnson 10-Q – Quarterly Report – 10-Q | ||
| JNJ / Johnson & Johnson 10-Q – Quarterly Report – 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 531,581 | 6,078,300 | 8.75 | |
| 453,156 | 6,142,500 | 7.38 | |
| 476,105 | 8,505,200 | 5.60 | |
| 483,102 | 6,190,500 | 7.80 | |
(click for more detail) |
|||
(click for list of largest short owners) |
|||
| Similar Companies | |
|---|---|
| EBS – Emergent Biosolutions, Inc. | FRX – Forest Laboratories Inc |
| HSP – Hospira | LCI – Lannett Co., Inc. |
| LLY – Eli Lilly & Co. |
Financial data and stock pages provided by
Fintel.io
2018/07/06
Also Read
